Second Parkinson’s Group in Phase 1 Trial Receives ISCO’s Neural Stem Cell Therapy – Parkinson’s News Today
Parkinson’s News Today |
Second Parkinson's Group in Phase 1 Trial Receives ISCO's Neural Stem Cell Therapy
Parkinson’s News Today A second group of Parkinson's patients in a Phase 1 clinical trial have received International Stem Cell Corporation's neural stem cell therapy. The main goal of the trial (NCT02452723) at Royal Melbourne Hospital is to see whether ISCO's stem cell … |
